Innovations in Heart Failure: Highlights and Insights From AHA 2021*

At AHA 2021, some major clinical trials broke new ground with familiar agents while others validated management approaches previously informed largely by clinical experience. Here’s my take.

Lee R. Goldberg, MD, MPH, FACC Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: December 8, 2021 Expired: No longer available for credit

Here are my thoughts on the exciting studies of novel therapies in heart failure, including a myosin inhibitor, statin use, and electrical cardioversion for atrial fibrillation.

Lee R. Goldberg, MD, MPH, FACC Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: December 9, 2021 Expired: No longer available for credit

At AHA 2021, new data on the use of telehealth platforms demonstrated that video visits are a feasible approach to managing patients with heart failure.

Lee R. Goldberg, MD, MPH, FACC Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: December 13, 2021 Expired: No longer available for credit